Respiratory Syncytial Virus Infection and Recurrent Wheezing: A Complex Relationship

Journal of Pediatrics

Volumn 151, Issue 1, 2007, Pages 6-7

  Meissner, H Cody ^a   Long, Sarah S ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHIOLITIS; CLINICAL OBSERVATION; CONTROL GROUP; DISEASE ASSOCIATION; EDITORIAL; FOLLOW UP; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION; WHEEZING;

ANTIVIRAL AGENTS; BRONCHIOLITIS, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; RECURRENCE; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34250662673     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.02.034     Document Type: Editorial

References (15)

1. Hall C.B., and McCarthy C.A. Respiratory syncytial virus. In: Mandell, Bennett, and Dolin (Eds). Principles and practice of infectious diseases. 6th ed. (2005), Elsevier Churchill Livingstone, Philadelphia 2009-2027
2. Welliver R.C. RSV and other respiratory viruses. Pediatr Infect Dis J 22 (2003) S6-S12
3. Taussig L.M., Wright A.L., Holberg C.J., Halonen M., Morgan W.J., and Martinez F.D. Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol 111 (2003) 661-675
4. Korppi M., Kotaniemi-Syrjanen A., Waris M., Vainionpaa R., and Reijonen T.M. Rhinovirus associated wheezing in infancy. Pediatr Infect Dis J 23 (2004) 995-999
5. Lemanske R.F. Viruses and asthma: inception, exacerbation, and possible prevention. J Pediatr 142 (2003) S3-S8
6. Eriksson M., Bennet R., and Nilsson A. Wheezing following lower respiratory tract infections with RSV and influenza A in infancy. Pediatr Allergy Immunol 11 (2000) 193-197
7. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M., et al. RSV in early life and risk of wheeze and allergy by 13 years. Lancet 354 (1999) 541-545
8. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., et al. Severe RSV bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171 (2005) 137-141
9. Martinez F.D. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proc Am Thorac Soc 2 (2005) 157-161
10. Simoes E.A.F., Groothuis J.R., Carbonell-Estrany X., Rieger C.H.L., Mitchell I., Fredrick L.M., et al. Palivizumab prophylaxis, RSV and subsequent recurrent wheezing. J Pediatr 151 (2007) 34-42
11. Shay D.K., Holman R.C., Newman R.D., Liu L.L., Stout J.W., and Anderson L.J. Bronchiolitis associated hospitalizations among United States children, 1980-1996. JAMA 282 (1999) 1440-1446
12. Akinbami L.J., and Schoendorf K.C. Trends in childhood asthma: prevalence, health care utilization and mortality. Pediatrics 110 (2002) 315-322
13. IMPACT-RSV study group. Palivizumab, a humanized RSV monoclonal antibody, reduces hospitalization from RSV infection in high risk infants. Pediatrics 102 (1998) 531-537
14. Collins P.L., and Murphy B.R. New generation live vaccines against human RSV designed by reverse genetics. Proc Am Thorac Soc 2 (2005) 166-173
15. AAP. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112 (2003) 1442-1446